NAD+: A Research Overview

NAD+ (nicotinamide adenine dinucleotide) is arguably the single most important molecule in contemporary longevity research. As the obligate co-substrate for sirtuins and PARP enzymes, it sits at the nexus of cellular energy metabolism, DNA repair, and epigenetic regulation.

What is NAD+?

NAD+ is a coenzyme found in every living cell, fundamental to energy metabolism and cellular signalling. It cycles between its oxidised (NAD+) and reduced (NADH) forms, serving as an electron carrier in the electron transport chain — the primary mechanism of cellular ATP production. Beyond metabolism, NAD+ serves as a substrate for three classes of NAD+-consuming enzymes: sirtuins (SIRT1–7), PARPs (poly ADP-ribose polymerases), and CD38/CD157 cyclases.

Circulating NAD+ levels decline by approximately 50% between ages 40 and 60 in humans — a decline that correlates with hallmarks of biological aging including mitochondrial dysfunction, genomic instability, epigenetic alterations, and increased inflammation. Understanding and potentially reversing this decline is one of the most active areas of longevity research globally.

Key Mechanisms

Mitochondrial Electron Transport

NAD+/NADH couples with complex I of the electron transport chain in mitochondria. This redox cycling is fundamental to oxidative phosphorylation — without adequate NAD+, ATP production is compromised. Research suggests that age-related NAD+ decline may be a primary driving factor in mitochondrial dysfunction observed in aging tissues.

Sirtuin Activation (SIRT1–7)

NAD+ is the obligate co-substrate for the sirtuin family of deacylase enzymes — the most studied longevity-associated protein family in molecular biology. SIRT1 deacetylates histones (H3K9, H3K14) and non-histone targets (p53, FOXO, PGC-1α, NF-κB) to regulate gene expression, mitochondrial biogenesis, inflammatory response, and stress resistance. SIRT3, 4, and 5 are mitochondrial sirtuins that regulate metabolic enzyme acetylation status.

Without NAD+, sirtuins are inactive. The rate of sirtuin-mediated deacetylation is directly proportional to cellular NAD+ availability — making NAD+ levels a key regulator of sirtuin activity in vivo.

PARP-Dependent DNA Repair

PARP-1 (poly ADP-ribose polymerase) is the most abundant NAD+-consuming enzyme. Activated by DNA strand breaks, PARP-1 cleaves NAD+ to produce poly-ADP-ribose chains attached to target proteins at damage sites — facilitating DNA repair complex recruitment. PARP-1 activation is a major consumer of cellular NAD+, particularly under conditions of genotoxic stress. Each PARP-1 molecule can consume hundreds of NAD+ molecules per minute at full activation.

CD38 and Age-Related NAD+ Decline

CD38 is a transmembrane NADase highly expressed in immune cells and inflammatory tissues. Its expression increases with age, driven by age-related inflammation and senescence-associated secretory phenotype (SASP). CD38 is now understood to be a primary driver of age-related NAD+ decline — consuming NAD+ faster than salvage pathways can replenish it.

NAD+ Administration in Research

Two primary delivery routes are documented in the literature. Intravenous (IV) injection at 250 mg–1 g over 2–8 hours provides maximum bioavailability, while subcutaneous or intramuscular injection at 50–100 mg per dose provides a practical alternative for repeated administration protocols. Oral NAD+ itself has negligible bioavailability — oral precursors NMN and NR are studied at 250–1000 mg/day.

NAD+ is hygroscopic and light-sensitive. Lyophilized powder should be stored at -20°C for long-term stability or 2–8°C for short-term use. Once reconstituted, use within 24–48 hours — NAD+ in solution degrades rapidly compared to peptide-based compounds.

---